Patents by Inventor Daniel J Parks

Daniel J Parks has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20190031618
    Abstract: The present invention is directed to benzimidazole derivatives, pharmaceutical compositions containing them and their use in the treatment of disorders and conditions mediated by the CB-1 receptor, more particularly, use in the treatment of disorders and conditions responsive to inverse agonism of the CB-1 receptor. More particularly, the compounds of the present invention are useful in the treatment of metabolic disorders.
    Type: Application
    Filed: October 3, 2018
    Publication date: January 31, 2019
    Applicant: Janssen Pharmaceutica NV
    Inventors: Mark J. Macielag, Rui Zhang, Yue-Mei Zhang, Bin Zhu, Michael H. Parker, Donald W. Ludovici, Daniel J. Parks, Bart L. DeCorte, Michael N. Greco
  • Patent number: 10118900
    Abstract: The present invention is directed to benzimidazole derivatives, pharmaceutical compositions containing them and their use in the treatment of disorders and conditions mediated by the CB-1 receptor; more particularly, use in the treatment of disorders and conditions responsive to inverse agonism of the CB-1 receptor. More particularly, the compounds of the present invention are useful in the treatment of metabolic disorders.
    Type: Grant
    Filed: August 23, 2016
    Date of Patent: November 6, 2018
    Assignee: Janssen Pharmaceutica NV
    Inventors: Mark J. Macielag, Rui Zhang, Yue-Mei Zhang, Bin Zhu, Michael H. Parker, Donald W. Ludovici, Daniel J. Parks, Bart L. DeCorte, Michael N. Greco
  • Patent number: 9718820
    Abstract: The present invention is directed to substituted aza-bicyclic imidazole derivatives, pharmaceutical compositions containing them and their use in the treatment of disorders and conditions modulated by TRP M8, including for example, inflammatory pain, inflammatory hyperalgesia, inflammatory hypersensitivity condition, neuropathic pain, neuropathic cold allodynia, inflammatory somatic hyperalgesia, inflammatory visceral hyperalgesia, cardiovascular disease aggravated by cold and pulmonary disease aggravated by cold.
    Type: Grant
    Filed: June 29, 2016
    Date of Patent: August 1, 2017
    Assignee: JANSSEN PHARMACEUTICA NV
    Inventors: Mark R. Player, Raul Calvo, Jinsheng Chen, Sanath Meegalla, Daniel J. Parks, William J. Parsons, Scott Ballentine, Shawn Branum
  • Publication number: 20170057929
    Abstract: The present invention is directed to benzimidazole derivatives, pharmaceutical compositions containing them and their use in the treatment of disorders and conditions mediated by the CB-1 receptor; more particularly, use in the treatment of disorders and conditions responsive to inverse agonism of the CB-1 receptor. More particularly, the compounds of the present invention are useful in the treatment of metabolic disorders.
    Type: Application
    Filed: August 23, 2016
    Publication date: March 2, 2017
    Applicant: Janssen Pharmaceutica NV
    Inventors: Mark J. Macielag, Rui Zhang, Yue-Mei Zhang, Bin Zhu, Michael H. Parker, Donald W. Ludovici, Daniel J. Parks, Bart L. DeCorte, Michael N. Greco
  • Publication number: 20160304518
    Abstract: The present invention is directed to substituted aza-bicyclic imidazole derivatives, pharmaceutical compositions containing them and their use in the treatment of disorders and conditions modulated by TRP M8, including for example, inflammatory pain, inflammatory hyperalgesia, inflammatory hypersensitivity condition, neuropathic pain, neuropathic cold allodynia, inflammatory somatic hyperalgesia, inflammatory visceral hyperalgesia, cardiovascular disease aggravated by cold and pulmonary disease aggravated by cold.
    Type: Application
    Filed: June 29, 2016
    Publication date: October 20, 2016
    Inventors: Mark R. Player, Raul Calvo, Jinsheng Chen, Sanath Meegalla, Daniel J. Parks, William J. Parsons, Scott Ballentine, Shawn Branum
  • Patent number: 9409915
    Abstract: The present invention is directed to substituted aza-bicyclic imidazole derivatives, pharmaceutical compositions containing them and their use in the treatment of disorders and conditions modulated by TRP M8, including for example, inflammatory pain, inflammatory hyperalgesia, inflammatory hypersensitivity condition, neuropathic pain, neuropathic cold allodynia, inflammatory somatic hyperalgesia, inflammatory visceral hyperalgesia, cardiovascular disease aggravated by cold and pulmonary disease aggravated by cold.
    Type: Grant
    Filed: February 17, 2015
    Date of Patent: August 9, 2016
    Assignee: Janssen Pharmaceutica NV
    Inventors: Mark R. Player, Raul Calvo, Jinsheng Chen, Sanath Meegalla, Daniel J. Parks, William J. Parsons, Scott Ballentine, Shawn Branum
  • Patent number: 9249163
    Abstract: Disclosed are compounds, compositions and methods for treating Type II diabetes and other disorders affected by activity of the enzyme PDE10a. Such compounds are represented by Formula (I) below, wherein R1, R2, L and Q are defined herein.
    Type: Grant
    Filed: June 9, 2014
    Date of Patent: February 2, 2016
    Assignee: JANSSEN PHARMACEUTICA NV.
    Inventors: Mark R. Player, Sanath K. Meegalla, Carl R. Illig, Jinsheng Chen, Kenneth J. Wilson, Yu-Kai Lee, Daniel J. Parks, Hui Huang, Sharmila Patel, Tianbao Lu
  • Patent number: 9193736
    Abstract: Disclosed are compounds, compositions and methods for treating Type II diabetes. Such compounds are represented by Formula (I) as follows: wherein R1, R2, L, and Q are defined herein.
    Type: Grant
    Filed: June 9, 2014
    Date of Patent: November 24, 2015
    Assignee: Janssen Pharmaceutica, NV
    Inventors: Mark R. Player, Sanath K. Meegalla, Carl R. Illig, Jinsheng Chen, Kenneth J. Wilson, Yu-Kai Lee, Daniel J. Parks, Wing S. Cheung, Hui Huang, Raymond J. Patch
  • Patent number: 9122285
    Abstract: A virtual thermostat system and method are provided. The method accepts commands via a virtual thermostat interface for establishing temperature set points for a plurality of zones. Energy consumption information is also accepted from a plurality of energy consumption units. Each unit consumes energy at an associated peak power to supply a controlled temperature medium to a corresponding zone. The method also accepts temperature measurements for each zone. Then, consumption commands are sent to each energy consumption unit in response to associated zone temperature set points, while insuring that a combined peak power of the energy consumption units is less than a maximum peak power threshold. In one aspect, the virtual thermostat accepts temperature measurements from a plurality of physical thermostats, each associated with an energy consumption unit. Then, consumption commands are relayed to the energy consumption units via associated physical thermostats.
    Type: Grant
    Filed: June 29, 2012
    Date of Patent: September 1, 2015
    Assignee: Sharp Laboratories of America, Inc.
    Inventors: Carl Mansfield, Daniel J. Park, David Elrod
  • Patent number: 9081043
    Abstract: A system and method are provided for calculating power using a voltage waveform shape measurement from a contactless sensor. An electrically conductive medium carries alternating current (AC) electrical current, associated with an AC voltage, from a source node to a destination node. AC current is measured through the electrically conductive medium. Using a contactless sensor, an AC voltage waveform shape is measured. The power usage at the destination node is calculated in response to the AC current measurement, the measurement of the AC voltage waveform shape, and an AC voltage potential. For simplicity, the AC current and AC voltage waveform shape may both be measured at a first node located between the source node and the destination node. The AC voltage potential used in the power usage calculation may be an estimate, an actual measurement, or a value supplied by an external source (e.g., the power utility).
    Type: Grant
    Filed: February 10, 2012
    Date of Patent: July 14, 2015
    Assignee: Sharp Laboratories of America, Inc.
    Inventors: Daniel J. Park, James E. Owen, David Elrod
  • Publication number: 20150158875
    Abstract: The present invention is directed to substituted aza-bicyclic imidazole derivatives, pharmaceutical compositions containing them and their use in the treatment of disorders and conditions modulated by TRP M8, including for example, inflammatory pain, inflammatory hyperalgesia, inflammatory hypersensitivity condition, neuropathic pain, neuropathic cold allodynia, inflammatory somatic hyperalgesia, inflammatory visceral hyperalgesia, cardiovascular disease aggravated by cold and pulmonary disease aggravated by cold.
    Type: Application
    Filed: February 17, 2015
    Publication date: June 11, 2015
    Inventors: Mark R. Player, Raul Calvo, Jinsheng Chen, Sanath Meegalla, Daniel J. Parks, William J. Parsons, Scott Ballentine, Shawn Branum
  • Patent number: 9023846
    Abstract: The present invention is directed to substituted aza-bicyclic imidazole derivatives, pharmaceutical compositions containing them and their use in the treatment of disorders and conditions modulated by TRP M8, including for example, inflammatory pain, inflammatory hyperalgesia, inflammatory hypersensitivity condition, neuropathic pain, neuropathic cold allodynia, inflammatory somatic hyperalgesia, inflammatory visceral hyperalgesia, cardiovascular disease aggravated by cold and pulmonary disease aggravated by cold.
    Type: Grant
    Filed: February 4, 2014
    Date of Patent: May 5, 2015
    Assignee: Janssen Pharmaceutica NV
    Inventors: Mark R Player, Raul Calvo, Jinsheng Chen, Sanath Meegalla, Daniel J. Parks, William J Parsons, Scott Ballentine, Shawn Branum
  • Publication number: 20140364414
    Abstract: Disclosed are compounds, compositions and methods for treating Type II diabetes. Such compounds are represented by Formula (I) as follows: wherein R1, R2, L, and Q are defined herein.
    Type: Application
    Filed: June 9, 2014
    Publication date: December 11, 2014
    Applicant: JANSSEN PHARMACEUTICA, NV
    Inventors: Mark R. Player, Sanath K. Meegalla, Carl R. Illig, Jinsheng Chen, Kenneth J. Wilson, Yu-Kai Lee, Daniel J. Parks, Hui Huang, Sharmila Patel, Tianbao Lu
  • Publication number: 20140364413
    Abstract: Disclosed are compounds, compositions and methods for treating Type II diabetes. Such compounds are represented by Formula (I) as follows: wherein R1, R2, L, and Q are defined herein.
    Type: Application
    Filed: June 9, 2014
    Publication date: December 11, 2014
    Applicant: Janssen Pharmaceutica, NV
    Inventors: Mark R. Player, Sanath K. Meegalla, Carl R. Illig, Jinsheng Chen, Kenneth J. Wilson, Yu-Kai Lee, Daniel J. Parks, Wing S. Cheung, Hui Huang, Raymond J. Patch
  • Patent number: 8725303
    Abstract: A multi-dimensional energy control system is provided with an energy management software application that organizes the consumption of energy by a device as an n-dimensional energy space, where n is an integer greater than 2, and each axis in the energy space represents an energy consumption characteristic. The energy management application generates instructions for a device in response to calculating a compromise operating point in the energy space. A user interface (UI) connected to the energy management application has a display to receive a graphical representation of the energy space and compromise operating point, and an input to receive user commands for moving the represented compromise operating point in the represented energy space. The energy management application calculates the compromise operating point in the energy space to match the displayed compromise operating point.
    Type: Grant
    Filed: July 8, 2011
    Date of Patent: May 13, 2014
    Assignee: Sharp Laboratories of America, Inc.
    Inventors: Daniel J. Park, James E. Owen, Carl Mansfield, David Elrod
  • Publication number: 20130211751
    Abstract: A system and method are provided for calculating power using a voltage waveform shape measurement from a contactless sensor. An electrically conductive medium carries alternating current (AC) electrical current, associated with an AC voltage, from a source node to a destination node. AC current is measured through the electrically conductive medium. Using a contactless sensor, an AC voltage waveform shape is measured. The power usage at the destination node is calculated in response to the AC current measurement, the measurement of the AC voltage waveform shape, and an AC voltage potential. For simplicity, the AC current and AC voltage waveform shape may both be measured at a first node located between the source node and the destination node. The AC voltage potential used in the power usage calculation may be an estimate, an actual measurement, or a value supplied by an external source (e.g., the power utility).
    Type: Application
    Filed: February 10, 2012
    Publication date: August 15, 2013
    Inventors: Daniel J. PARK, James E. OWEN, David ELROD
  • Publication number: 20130184170
    Abstract: The present invention relates generally to the field of diagnostic and detection assays. More particularly, the present invention provides methods and reagents including biochips for detecting the presence of, or distinguishing between, one or more analytes in a sample.
    Type: Application
    Filed: June 4, 2012
    Publication date: July 18, 2013
    Applicant: GENERA BIOSYSTEMS LIMITED
    Inventors: DANIEL J. PARK, ZAHEER KHAN, KARL F. POETTER
  • Patent number: 8473107
    Abstract: Systems and devices for, and methods of, energy management via prompted response options based on detected anomalous conditions.
    Type: Grant
    Filed: August 5, 2010
    Date of Patent: June 25, 2013
    Assignee: Sharp Laboratories of America, Inc.
    Inventor: Daniel J. Park
  • Patent number: 8359125
    Abstract: Systems and devices for, and methods of, adaptive local energy storage capacity by changing operating set points of regulated energy load devices based on the presence, or absence, of an excess of available, generated energy.
    Type: Grant
    Filed: June 17, 2010
    Date of Patent: January 22, 2013
    Assignee: Sharp Laboratories of America, Inc.
    Inventor: Daniel J. Park
  • Publication number: 20130013119
    Abstract: A virtual thermostat system and method are provided. The method accepts commands via a virtual thermostat interface for establishing temperature set points for a plurality of zones. Energy consumption information is also accepted from a plurality of energy consumption units. Each unit consumes energy at an associated peak power to supply a controlled temperature medium to a corresponding zone. The method also accepts temperature measurements for each zone. Then, consumption commands are sent to each energy consumption unit in response to associated zone temperature set points, while insuring that a combined peak power of the energy consumption units is less than a maximum peak power threshold. In one aspect, the virtual thermostat accepts temperature measurements from a plurality of physical thermostats, each associated with an energy consumption unit. Then, consumption commands are relayed to the energy consumption units via associated physical thermostats.
    Type: Application
    Filed: June 29, 2012
    Publication date: January 10, 2013
    Inventors: Carl Mansfield, Daniel J. Park, David Elrod